Investigating a potential class action lawsuit against the makers of the herbal product kratom for positioning the product as a safe alternative to opioids. Kratom is an unregulated supplement that the Food and Drug Administration (FDA) stated is an opioid and is "expected to have similar addictive effects as well as risks of abuse, overdose and, in some cases, death." The FDA Commissioner goes on to say, “We know that some patients are using kratom because they believe it can help treat their opioid dependency, but there’s no reliable evidence to support kratom’s effectiveness for this use." The FDA has taken an additional step on September 11, 2018 of issuing warning letters to Chillin Mix Kratom and Mitra Distributing for continuing to use false and unsubstantiated marketing claims about their kratom products. The companies claim their products "relieve opium withdrawals” and treat medical conditions including diarrhea, depression, diabetes, obesity, high blood pressure, stomach parasites, diverticulitis, anxiety and alcoholism. If you or a loved one has used kratom (marketed under a variety of brand names), please submit your information below.